Financial Avengers’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Hold |
200
| – | – | 0.01% | 101 |
|
|
2025
Q1 | $12.7K | Hold |
200
| – | – | 0.01% | 106 |
|
|
2024
Q4 | $13.3K | Hold |
200
| – | – | 0.01% | 117 |
|
|
2024
Q3 | $14K | Hold |
200
| – | – | 0.01% | 120 |
|
|
2024
Q2 | $12.9K | Hold |
200
| – | – | 0.01% | 106 |
|
|
2024
Q1 | $12.9K | Hold |
200
| – | – | 0.01% | 95 |
|
|
2023
Q4 | $13.1K | Hold |
200
| – | – | 0.01% | 103 |
|
|
2023
Q3 | $11.4K | Hold |
200
| – | – | 0.01% | 105 |
|
|
2023
Q2 | $12.2K | Hold |
200
| – | – | 0.01% | 100 |
|
|
2023
Q1 | $12.5K | Hold |
200
| – | – | 0.01% | 100 |
|
|
2022
Q4 | $12.7K | Hold |
200
| – | – | 0.01% | 94 |
|
|
2022
Q3 | $12K | Hold |
200
| – | – | 0.01% | 91 |
|
|
2022
Q2 | $12K | Hold |
200
| – | – | 0.01% | 100 |
|
|
2022
Q1 | $12K | Hold |
200
| – | – | 0.01% | 112 |
|
|
2021
Q4 | $14K | Hold |
200
| – | – | 0.01% | 111 |
|
|
2021
Q3 | $15K | Hold |
200
| – | – | 0.01% | 99 |
|
|
2021
Q2 | $15K | Hold |
200
| – | – | 0.01% | 105 |
|
|
2021
Q1 | $15K | Hold |
200
| – | – | 0.01% | 104 |
|
|
2020
Q4 | $14K | Buy |
+200
| New | +$14K | 0.01% | 100 |
|